Source Natural Foods Stock Screener | Share Price & Fundamental Analysis
SOURCENTRL
Pharmaceuticals
Screen Source Natural Foods share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹132.10
▼
-3.25 (-2.40%)
Market Cap
₹88.72 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
3.62
EPS (TTM)
₹4.51
Dividend Yield
-
Debt to Equity
0.21
52W High
₹208.15
52W Low
₹122.10
Operating Margin
11.00%
Profit Margin
5.36%
Revenue (TTM)
₹56.00
EBITDA
₹6.00
Net Income
₹3.00
Total Assets
₹36.00
Total Equity
₹22.00
Source Natural Foods Share Price History - Stock Screener Chart
Screen SOURCENTRL historical share price movements with interactive charts. Analyze price trends and patterns.
Source Natural Foods Company Profile - Fundamental Screener
Screen Source Natural Foods company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SOURCENTRL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE679C01027
Source Natural Foods Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SOURCENTRL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 36 | 24 | 22 | 19 | 17 | 13 | 11 | 11 | 12 | 7 |
| Current Assets | 26 | 18 | 15 | 14 | 11 | 9 | 6 | 7 | 8 | 3 |
| Fixed Assets | 5 | 6 | 7 | 5 | 4 | 3 | 4 | 4 | 4 | 3 |
| Liabilities | ||||||||||
| Total Liabilities | 36 | 24 | 22 | 19 | 17 | 13 | 11 | 11 | 12 | 7 |
| Current Liabilities | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 22 | 20 | 18 | 16 | 13 | 10 | 9 | 8 | 7 | 6 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 16 | 13 | 11 | 9 | 7 | 3 | 2 | 1 | 1 | -1 |
Screen SOURCENTRL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 56 | 45 | 27 | 20 | 22 | 25 | 14 | 13 | 11 | 16 | 11 | 7 |
| Expenses | 50 | 40 | 23 | 16 | 18 | 21 | 11 | 11 | 10 | 14 | 10 | 6 |
| EBITDA | 6 | 5 | 5 | 4 | 4 | 5 | 2 | 2 | 1 | 2 | 1 | 1 |
| Operating Profit % | 11.00% | 11.00% | 16.00% | 18.00% | 17.00% | 17.00% | 17.00% | 12.00% | 13.00% | 11.00% | 9.00% | 11.00% |
| Depreciation | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 4 | 4 | 3 | 3 | 4 | 4 | 2 | 1 | 1 | 1 | 1 | 0 |
| Tax | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 3 | 3 | 2 | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 0 | 0 |
| EPS | 4.60 | 4.51 | 2.70 | 3.30 | 3.78 | 5.24 | 2.55 | 1.59 | 1.24 | 2.18 | 0.66 | 0.26 |
Source Natural Foods Cash Flow Screener - Liquidity Fundamentals
Screen SOURCENTRL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 3 | 3 | -1 | 5 | 0 | 3 | 0 | -1 | 0 |
| Investing Activities | -5 | 0 | 0 | 0 | -2 | -1 | 0 | 0 | -2 | 0 |
| Financing Activities | 5 | 1 | -1 | -1 | 0 | 0 | -2 | 0 | 2 | 0 |
| Net Cash Flow | 0 | 4 | 2 | -2 | 3 | -1 | 1 | 0 | -1 | 0 |
Screen SOURCENTRL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 18.79% | 18.96% | 19.98% | 20.30% | 22.99% | 22.54% | 21.38% | 21.40% |
| Other Holding | 6.84% | 6.67% | 5.65% | 5.33% | 2.64% | 3.09% | 4.25% | 4.23% |
| Shareholder Count | 3,778 | 3,752 | 3,849 | 3,864 | 3,834 | 3,966 | 3,387 | 3,271 |
Source Natural Foods Dividend Screener - Share Yield Analysis
Screen SOURCENTRL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.00 | 1.38% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Source Natural Foods Index Membership - Market Screener Classification
Screen SOURCENTRL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Source Natural Foods Market Events Screener - Corporate Actions
Screen SOURCENTRL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -0.15% | ||
| Annual General Meeting | NA | -7.93% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -2.54% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -2.93% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 3.56% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -6.79% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 6.09% |
Source Natural Foods Competitors Screener - Peer Comparison
Screen SOURCENTRL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 421,299 | 40.53 | 54,729 | 9.71% | 10,980 | 46.18 |
| Divis Laboratories | 171,931 | 69.57 | 9,712 | 18.67% | 2,191 | 53.62 |
| Torrent Pharmaceuticals | 129,290 | 60.33 | 11,539 | 6.99% | 1,911 | 62.04 |
| Cipla | 121,220 | 22.48 | 28,410 | 7.12% | 5,291 | 44.91 |
| Dr Reddys Laboratories | 107,123 | 18.68 | 33,741 | 16.73% | 5,725 | 60.09 |
| Lupin | 96,535 | 22.34 | 22,910 | 13.74% | 3,306 | 60.88 |
| Zydus Life Science | 93,358 | 18.37 | 23,511 | 18.55% | 4,615 | 47.29 |
| Mankind Pharma | 92,029 | 50.91 | 12,744 | 20.90% | 2,007 | 53.62 |
| Aurobindo Pharma | 70,742 | 20.79 | 32,346 | 9.43% | 3,484 | 57.50 |
| Alkem Laboratories | 66,921 | 27.88 | 13,458 | 3.70% | 2,216 | 47.48 |
Source Natural Foods Company Announcements - News Screener
Screen SOURCENTRL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025. | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-11-10 | Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025. | View |
| 2025-10-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-04 | Announcement Under Regulation 30 - Reconstitution Of Committees. | View |
| 2025-09-30 | Closure of Trading Window | View |
| 2025-09-29 | Announcement under Regulation 30 (LODR)-Retirement | View |
| 2025-09-27 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |
| 2025-09-27 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-09-27 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-03 | Intimation Of Book Closure And Record Date For The Purpose Of 30Th Annual General Meeting (AGM). | View |
| 2025-09-03 | Notice Of 30Th Annual General Meeting ("AGM") Of The Company. | View |
| 2025-09-03 | Reg. 34 (1) Annual Report. | View |
| 2025-09-01 | Submission Of Revised Corporate Announcement Regarding Additional Details Required For Appointment Of Director. | View |
| 2025-08-30 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-08-26 | Board Meeting Intimation for Consideration Of Appointment Of New Independent Director And Other AGM Related Items. | View |
| 2025-08-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |